首页> 外文期刊>Cancer Management and Research >Disclosure of cancer diagnosis in China: the incidence, patients’ situation, and different preferences between patients and their family members and related influence factors
【24h】

Disclosure of cancer diagnosis in China: the incidence, patients’ situation, and different preferences between patients and their family members and related influence factors

机译:中国癌症诊断的披露:发病率,患者状况,患者及其家庭成员之间的不同偏好以及相关的影响因素

获取原文
           

摘要

Purpose: The purpose of this study was to investigate the disclosure incidence of cancer diagnosis to patients before chemotherapy, to survey the attitudes of the patients and their families and related influencing factors toward disclosure of cancer diagnosis, and to compare the anxiety and depression levels between the disclosure and non-disclosure patients. Participants and methods: A prospective cohort study was conducted at a tertiary hospital in China. A consecutive series of patients who had been diagnosed with malignancy by pathology and their family member were included in our study from March 2017 to December 2017. Patients’ situation, preferences, and their family members’ preferences were investigated by a self-designed questionnaire following a semi-structured interview. The Chinese version of HADS for anxiety and depression was used to test the patients’ psychological distress. Binary logistic regression was used to analyze the related influencing factors of patients’ disclosure of their diagnosis. Results: A total of 124 pairs of patients and their family members were analyzed. Of the 124 patients, 47 (37.90%) patients knew about their cancer diagnosis and 77 (62.10%) patients did not know about their cancer diagnosis before chemotherapy. There were more patients than family members who wanted the patients to be informed about the diagnosis of terminal illness (91.9% vs 53.2%, P 0.01). Binary logistic regression analysis showed that patients with university education (odds ratio [OR], 15.322; 95% confidence interval [CI], 1.781–131.781; P 0.05), patients having equal or above average annual income (OR, 5.170; 95% CI, 1.842–14.514; P 0.01) were more likely informed about cancer diagnosis before chemotherapy. Higher anxiety level was found in diagnosis non-disclosure group ( P 0.05). Conclusion: More than half of the patients did not know their exact diagnosis before chemotherapy in China. Educational level and economic status may be influencing factors for the disclosure of cancer diagnosis. Patients and their family members had different preferences toward diagnosis disclosure.
机译:目的:本研究的目的是调查化疗前对患者的癌症诊断披露发生率,调查患者及其家属的态度以及对癌症诊断披露的相关影响因素,并比较两者之间的焦虑和抑郁水平。公开和不公开的患者。参与者和方法:前瞻性队列研究在中国一家三级医院进行。 2017年3月至2017年12月,本研究纳入了一系列经病理学诊断为恶性肿瘤的患者及其家属。通过以下设计的问卷调查了患者的情况,偏好和家庭成员的偏好半结构化访谈。用中文版的HADS评估焦虑和抑郁的情况来测试患者的心理困扰。采用二元逻辑回归分析分析患者披露诊断信息的相关影响因素。结果:共分析了124对患者及其家属。在124位患者中,有47位(37.90%)患者了解他们的癌症诊断,而77位(62.10%)患者不了解化疗之前的癌症诊断。希望患者了解绝症诊断的患者比家庭成员多(91.9%对53.2%,P <0.01)。二元logistic回归分析显示,大学学历患者(几率[OR]为15.322; 95%置信区间[CI]为1.781–131.781; P <0.05),这些患者的年收入均等或更高(OR为5.170; 95) %CI(1.842–14.514; P <0.01)更有可能在化疗前获得有关癌症诊断的信息。诊断未披露组的焦虑水平较高(P 0.05)。结论:中国有超过一半的患者在化疗之前不知道确切的诊断。受教育程度和经济状况可能是影响癌症诊断披露的因素。患者及其家人对诊断披露的偏好不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号